A COPD health management program in a community-based primary care setting: A randomized controlled trial

Respiratory Care

Volumn 60, Issue 1, 2015, Pages 102-112

  Lou, Peian ^a   Chen, Peipei ^a   Zhang, Pan ^a   Yu, Jiaxi ^a   Wang, Yong ^a   Chen, Na ^a   Zhang, Li ^a   Wu, Hongmin ^b   Zhao, Jing ^b  

^a Xuzhou Center for Disease Control and Prevention   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

BODE index; COPD; Health management; Health status

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; IMMUNOMODULATING AGENT; THEOPHYLLINE; IMMUNOLOGIC FACTOR;

AGED; AIRWAY OBSTRUCTION; ANXIETY; ARTICLE; AWARENESS; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEPRESSION; DYSPNEA; EXERCISE; FEMALE; FOLLOW UP; HEALTH CARE MANAGEMENT; HEALTH EDUCATION; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RURAL POPULATION; SMOKING; SMOKING CESSATION PROGRAM; ATTITUDE TO HEALTH; BREATHING EXERCISE; CHINA; CLINICAL PRACTICE; COMMUNITY CARE; DIET; DIRECTIVE COUNSELING; EMERGENCY HEALTH SERVICE; EPIDEMIOLOGY; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT EDUCATION; PROCEDURES; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RURAL HEALTH CARE; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AGED; ANXIETY; BODY MASS INDEX; BREATHING EXERCISES; CHINA; COMMUNITY HEALTH SERVICES; DEPRESSION; DIET; DIRECTIVE COUNSELING; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; EXERCISE; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOSPITALIZATION; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RURAL HEALTH SERVICES; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION;

EID: 84935121602     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.03420     Document Type: Article

References (41)

1. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370(9589):797-799.
2. Bailey WC, Tashkin DP. Pharmacologic therapy: novel approaches for chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007;4(7):543-548.
3. Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD. Chest 2011:139(1): 165-173.
4. Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys 2007;43(4):475-485.
5. van Wetering CR, Hoogendoorn M, Mol SJ, Rutten-van Mölken MP, Schols AM. Short-and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax 2010;65(1):7-13.
6. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 2002;288(15): 1909-1914.
7. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007;131(5 Suppl):4S-42S.
8. Ergün P, Kaymaz D, Günay E, Erdoğan Y, Turay UY, Demir N, et al. Comprehensive outpatient pulmonary rehabilitation: treatment outcomes in early and late stages of chronic obstructive pulmonary disease. Ann Thorac Med 2011;6(2):70-76.
9. Rice KL, Dewan N, Bloomfield HE, Grill J, Schult TM, Nelson DB, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2010; 182(7):890-896.
10. Tsui EW, Wang G, Zahler A, Simoyan OM, White MV, Mckee M. A multilingual population health management program. J Ambul Care Manage 2013:36(2): 140-146.
11. Lou P, Zhu Y, Chen P, Zhang P, Yu J, Zhang N, et al. Vulnerability, beliefs, treatments and economic burden of chronic obstructive pulmonary disease in rural areas in China: a cross-sectional study. BMC Public Health 2012;12:287.
12. Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2011. http://www.goldcopd.org/up loads/users/files/GOLD_Report_201 l_Jan21.pdf. Accessed September 18, 2014.
13. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10): 1005-1012.
14. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1): 111-117.
15. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581-586.
16. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002;52(2):69-77.
17. van Wetering CR. Hoogendoorn M, Broekhuizen R, Geraerts-Keeris GJ, De Munck DR, Rutten-van Mölken MP, Schols AM. Effective and costs of nutritional rehabilitation in muscle-waste patients with chronic obstructive pulmonary disease in community-based setting: a prespecified subgroup analysis of the INTERCOM trail. J Am Med Dir Assoc 2010;11(3): 179-187.
18. Zhou Y, Hu G, Wang D, Wang S, Wang Y, Liu Z, et al. Community-based integrated intervention for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: cluster randomised controlled trial. BMJ 2010;341 :c6387.
19. Browner WS, Du Chene AG, Hulley SB. Effects of the Multiple Risk Factor Intervention Trial smoking cessation program on pulmonary function-a randomized controlled trial. West J Med 1992:157(5): 534-538.
20. 1 the lung health study. JAMA 1994;272(19): 1497-1505.
21. Ferrari R, Tanni SE, Faganello MM, Caram LM, Lucheta PA, Godoy I. Three-year follow-up study of respiratory and systemic manifestations of chronic obstructive pulmonary disease. Braz J Med Biol Res 2011;44(1):46-52.
22. Casanova C, Cote CG, Marin JM, de Torres JP, Aguirre-Jaime A, Mendez R, et al. The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J 2007;29(3):535-540.
23. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004;364(9434):613-620.
24. Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, Vestbo J. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002;20(4):799-805.
25. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 2006; 100(10): 1767-1774.
26. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-555.
27. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370(9589):765-773.
28. Willemse BW, ten Hacken NH, Rutgers B, Lesman-Leegte IG, Postma DS, Timens W. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J 2005; 26(5):835-845.
29. 1: results from the Lung Health Study. Eur Respir J 2005;25(6):1011-1017.
30. Au DH, Bryson CL, Chien JW, Sun H, Udris EM, Evans LE, Bradley KA. The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med 2009; 24(4):457-463.
31. Godtfredsen NS, Lam TH, Hansel TT, Leon ME, Gray N, Dresler C, et al. COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J 2008;32(4):844-853.
32. Celli BR, Update on the management of COPD. Chest 2008; 133(6): 1451-1462.
33. Zhou Y, Wang C, Yao W, Chen P, Kang J, Huang S, et al. COPD in Chinese nonsmokers. Eur Respir J 2009;33(3):509-518.
34. Hu G, Zhou Y, Tian J, Yao W, Li J, Li B, Ran P. Risk of COPD from exposure to biomass smoke: a Metaanalysis. Chest 2010; 138(1);20- 31.
35. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD): a review. Nord J Psychiatry 2004;58(1):65-70.
36. Wilson I. Depression in the patient with COPD. Int J Chron Obstruct Pulmon Dis 2006; 1 (1):61-64.
37. Bösch D, Feierabend M, Becker A. COPD outpatient education programmer (ATEM) and BODE index. Pneumologie 2007;61(10):629-635.
38. Kunik ME, Braun U, Stanley MA, Wristers K, Molinari V, Stoebner D, Orengo CA. One session cognitive behavioral therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med 2001;31(4):717-723.
39. Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med 2008; 38(3):385-396.
40. Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsom-ritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004; 125(6):2011-2020.
41. Yu WC, Tai EL, Fu SN, Kwong KC, Yeung YC, Chang Y, et al. Treatment of patients with chronic obstructive pulmonary disease as practised in a defined Hong Kong community: a cross-sectional pilot survey. Hong Kong Med J 2011; 17(4);306-314.